Note: Ingredients listed on restricted chemical lists
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
EC/CAS
9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
N/A
EC/CAS
25956-17-6
Name of the chemical
Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate (17); (CI 16035)
Concentration
N/A
General Information
Revision date
2018-08-04
Product name
Azithromycin for oral suspension USP
Chemical name
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycinAdihydrate, N-methyl-11-aza- 10-deoxo-10-dihydroerythromycin A
1.2.1 Relevant identified uses
Therapeutic Category Macrolide
1.2.2. Uses advised against
/ Contraindications Patients should not take aluminum- and magnesium- containing antacids and azithromycin simultaneously
Icons in SDS
Company Information
company name
Cadila Healthcare Limited
Section 2
SECTION 2: Hazards identification
Dose and Administration Dosage should be individualized with careful monitoring of patient response. The recommended adult dosage for Azithromycin for Oral Suspension USP 100mg/5mL and 200mg/5mL in the treatment of Acute bacterial sinusitis is 500mg once daily for 3 days. Dosing regimen should be adjusted according to each patient’s need at the discretion of the physician. Adverse Effects Most common adverse reactions are diarrhea (5 to 14%), nausea (3 to 18%), abdominal pain (3 to 7%), or vomiting (2 to 7%). Over Dose Effect Adverse reactions experienced at higher than recommended doses were similar to those seen at normal doses particularly nausea, diarrhea, and vomiting. In the event of over dosage, general symptomatic and supportive measures are indicated as required. Contraindications Azithromycin for Oral Suspension USP is contraindicated in Patients with a history of cholestatic jaundice/hepatic dysfunction associated with prior use of azithromycin. Pregnancy Comments There are no adequate or well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human
Response
azithromycin should be used during pregnancy only if clearly needed. Reproduction studies have been performed in rats and mice at doses up to moderately maternally toxic dose concentrations (i.e., 200 mg/kg/day). These daily doses in rats and mice, based on body surface area, are estimated to be 4 and 2 times, respectively, an adult daily dose of 500 mg. In the animal studies, no evidence of harm to the fetus due to azithromycin was found. Pregnancy Category Pregnancy Category B